Brief: Diagonal Bio Announces Successful External Validation Of Lamplify
06/09/2024 11:06
Sept 6 (Reuters) - Diagonal Bio AB DIABIO.ST :
* DIAGONAL BIO ANNOUNCES SUCCESSFUL EXTERNAL VALIDATION OF
LAMPLIFY® FOR RESPIRATORY VIRUSES IN HORSES
Source text for Eikon: ID:nWkr3sy6bT
Further company coverage: DIABIO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Diagonal Bio AB
See all newsBrief: Diagonal Bio Approved For Delisting From Nasdaq First NGM
Brief: Diagonal Bio Gets Conditional Approval For Listing On NGM Nordic SME
Brief: Diagonal Bio Applies For Change Of Marketplace To NGM Nordic SME
Brief: Diagonal Bio Resolves On Directed Issue Of Units To All External Underwriters
Brief: Diagonal Bio Says Positive Pilot Test Results, Gets Order From Stallzet